We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

CABYR Isoforms As Targets for Specific Immunotherapy

News   May 18, 2021 | Original story from Impact Journals

 
CABYR Isoforms As Targets for Specific Immunotherapy
 
 
Advertisement
 

RELATED ARTICLES

Ovarian Cancer Treatment Proves Effective in Preclinical Model

News

Preclinical trials of Pb-214-labeled Trastuzumab, a new ovarian cancer treatment, have produced successful results, dramatically limiting tumor growth and decreasing tumor mass.

READ MORE

Omega-3 Fatty Acid Kills Tumor Cells in Culture

News

Docosahexaenoic acid (DHA) is an Omega-3 fatty acid that is associated with a reduction in the incidence of cancer. Researchers have discovered the biochemical mechanism that allows DHA to slow tumor development.

READ MORE

Bacteria Hijack Phage of Competitors To Defeat Them

News

Scientists were able to show for the first time how Pseudomonas bacteria use a self-produced signal molecule to manipulate phages in a competing bacterial strain selectively to defeat their enemy. This targeted control of phages provides entirely new biotechnological and therapeutic approaches.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Biopharma Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE